Remdesivir is a Gilead science antiviral medicine, patients in Chicago hospitals who are treated with the experimental drug have been recovering quickly, with most going home in days.
These is one of the first breakthrough in Covid19, if it yields further positive results it would likely lead to fast approvals by relevant drug authorities.
According to report from Stat News, “The University of Chicago Medicine recruited 125 people with Covid-19 into Gilead’s two Phase 3 clinical trials. Of those people, 113 had severe disease. All the patients have been treated with daily infusions of remdesivir.”
The best news is that most of our patients have already been discharged, which is great. We’ve only had two patients perish,” said Kathleen Mullane, the University of Chicago infectious disease specialist overseeing the remdesivir studies for the hospital.
These could be the breakthrough from Covid19 the world is waiting on.
Please share your views in the comment section.